Method of treating insufficiencies in hematosis with almitrine
AssigneeScience Union et Cie
InventorsEtienne Labeyrie, Jean-Pierre Poirier, Francoise Arnaud
Life of this patent
Estimating the term…
Abstract
A method of treating insufficiencies in hematosis, such as hypoxemia, cardiac insufficiency, and polyglobulia, involving treatment of a patient suffering from such insufficiency with the compound almitrine or a pharmaceutically-acceptable salt thereof in extremely low daily dosages, between 0.5 and 3 mg/kg orally or 0.05 to 0.3 mg/kg intravenously, an oral unit dosage form of the said active ingredient, containing between 20 and 70 mg of active ingredient together with a pharmaceutically-acceptable carrier or diluent, preferably about 50 mg of the active ingredient.
Claims7
A method of treating insufficiencies in hematosis in a patient suffering from such insufficiency comprising the step of administering to the said patient the compound almitrine or a pharmaceutically-acceptable salt thereof in an amount effective for such purpose by the oral or intravenous route, the said amount administered being 0.5 to 3 mg/kg/day by the oral route or 0.05 to 0.3 mg/kg/day by the intravenous route.
Dependencies are inferred from the claim text.